IL93895A - History of Asrolin's carbonate process and their pharmaceutical preparations - Google Patents

History of Asrolin's carbonate process and their pharmaceutical preparations

Info

Publication number
IL93895A
IL93895A IL9389590A IL9389590A IL93895A IL 93895 A IL93895 A IL 93895A IL 9389590 A IL9389590 A IL 9389590A IL 9389590 A IL9389590 A IL 9389590A IL 93895 A IL93895 A IL 93895A
Authority
IL
Israel
Prior art keywords
compound
formula
carbonate
indol
hexahydro
Prior art date
Application number
IL9389590A
Other languages
English (en)
Hebrew (he)
Other versions
IL93895A0 (en
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of IL93895A0 publication Critical patent/IL93895A0/xx
Publication of IL93895A publication Critical patent/IL93895A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9389590A 1989-03-27 1990-03-26 History of Asrolin's carbonate process and their pharmaceutical preparations IL93895A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/329,171 US4971992A (en) 1989-03-27 1989-03-27 Carbonate derivatives of eseroline

Publications (2)

Publication Number Publication Date
IL93895A0 IL93895A0 (en) 1990-12-23
IL93895A true IL93895A (en) 1995-07-31

Family

ID=23284183

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9389590A IL93895A (en) 1989-03-27 1990-03-26 History of Asrolin's carbonate process and their pharmaceutical preparations

Country Status (18)

Country Link
US (1) US4971992A (de)
EP (1) EP0389984B1 (de)
JP (1) JPH0737458B2 (de)
KR (1) KR0163049B1 (de)
AT (1) ATE124044T1 (de)
AU (1) AU621208B2 (de)
CA (1) CA2013087C (de)
DE (1) DE69020205T2 (de)
DK (1) DK0389984T3 (de)
ES (1) ES2075081T3 (de)
FI (1) FI92932C (de)
HU (1) HU204053B (de)
IE (1) IE67449B1 (de)
IL (1) IL93895A (de)
NO (1) NO173995C (de)
NZ (1) NZ233065A (de)
PT (1) PT93535B (de)
ZA (1) ZA902307B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US4983616A (en) * 1990-02-01 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
AU634654B2 (en) * 1990-05-11 1993-02-25 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo(2,3-b)indole-ketones and analogs, a process for their preparation and their use as medicaments
US5216017A (en) * 1990-05-11 1993-06-01 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo[2,3-b]indole-ketones and analogs
AU634380B2 (en) * 1990-05-17 1993-02-18 Hoechst-Roussel Pharmaceuticals Incorporated Alpha-oxopyrrolo(2,3-b)indole acetic acids, esters, amides and related analogs, a process for their preparation and their use as medicaments
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
US5409948A (en) * 1992-11-23 1995-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating cognitive disorders with phenserine
AT404907B (de) * 1993-07-13 1999-03-25 Andritz Patentverwaltung Verfahren und anlage zum herstellen von edelstahlband
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
US20050182044A1 (en) * 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
CA2508585A1 (en) * 2004-06-01 2005-12-01 Axonyx, Inc. Transdermal delivery system for treatment of cognitive disorders
EP1604686A1 (de) * 2004-06-08 2005-12-14 Axonyx, Inc. Verwendung von Phenserine und einem HMG CoA reduktase Hemmer zur Verzögerung der Alzheimer Krankheit

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1109003B (it) * 1977-09-20 1985-12-16 Univ Firenze Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine

Also Published As

Publication number Publication date
FI92932B (fi) 1994-10-14
FI92932C (fi) 1995-01-25
KR900014388A (ko) 1990-10-23
DE69020205D1 (de) 1995-07-27
EP0389984A1 (de) 1990-10-03
DE69020205T2 (de) 1995-12-07
AU621208B2 (en) 1992-03-05
AU5220290A (en) 1990-11-08
IL93895A0 (en) 1990-12-23
IE67449B1 (en) 1996-04-03
HU901832D0 (en) 1990-08-28
ES2075081T3 (es) 1995-10-01
KR0163049B1 (ko) 1998-12-01
JPH02289572A (ja) 1990-11-29
ZA902307B (en) 1990-12-28
JPH0737458B2 (ja) 1995-04-26
NZ233065A (en) 1992-04-28
CA2013087C (en) 1999-12-28
NO173995C (no) 1994-03-02
ATE124044T1 (de) 1995-07-15
NO901385L (no) 1990-09-28
US4971992A (en) 1990-11-20
NO173995B (no) 1993-11-22
HUT54159A (en) 1991-01-28
PT93535A (pt) 1990-11-07
EP0389984B1 (de) 1995-06-21
DK0389984T3 (da) 1995-10-30
FI901470A0 (fi) 1990-03-23
HU204053B (en) 1991-11-28
CA2013087A1 (en) 1990-09-27
NO901385D0 (no) 1990-03-26
IE901097L (en) 1990-09-27
PT93535B (pt) 1996-03-29

Similar Documents

Publication Publication Date Title
EP0417584B1 (de) N-Substituierte 4-Pyrimidinamine und -Pyrimidindiamine, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
US4971992A (en) Carbonate derivatives of eseroline
EP0656360B1 (de) Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung
US5017578A (en) N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
EP0799827B1 (de) Acrylamid-derivate und verfahren zu deren herstellung
EP0415103B1 (de) 2,3-Dihydro-1-(pyridinylamino)-indole, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
KR900001200B1 (ko) 치환된 4-알킬-2(1h)퀴나졸린온-1-알카노산 유도체의 제조방법
AU2007309558B2 (en) Crystal modifications -3- (1H-indol-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl] -pyrrole-2, 5-dione
US5173497A (en) Alpha-oxopyrrolo[2,3-B]indole acetic acids, esters, amides and related analogs
US5179204A (en) N-substituted-4-pyrimidinamines and pyrimidinediamines
US5109011A (en) P-acylaminophenoxycarbamates and derivatives
EP0461603A1 (de) Derivate der Verbindung DC-89
EP0457318B1 (de) Alpha-Oxopyrrolo(2,3-b)indolessigsäuren, Ester, Amide und verwandte Analoge, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US5264587A (en) Method of preparing α-oxopyrrolo[2,3-b]indole acetic acids and derivatives
US5155098A (en) N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them
JPS6087285A (ja) ピロリルアミノピペリジン化合物およびその製法
IE902437A1 (en) 6- and 7-Deoxyforskolin and derivatives thereof,¹intermediates and a process for their preparation and their¹use as medicaments
US4914103A (en) Pyrido(3,4-F)pyrrolo(1,2-B)(1,2,5)triazepines
EP0413433A1 (de) Isoindolyl-Imidazol-Derivate und pharmazeutische Zusammensetzungen

Legal Events

Date Code Title Description
RH Patent void
MM9K Patent not in force due to non-payment of renewal fees